# Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease

> **NCT02059512** · NA · COMPLETED · sponsor: **St. Petersburg State Pavlov Medical University** · enrollment: 117 (actual)

## Conditions studied

- Ischemic Heart Disease
- Bone Marrow Cells
- Coronary Artery Bypass Grafting (CABG)
- Heart Failure, Diastolic

## Interventions

- **PROCEDURE:** Group 1
- **PROCEDURE:** Group 0
- **PROCEDURE:** Group 2

## Key facts

- **NCT ID:** NCT02059512
- **Lead sponsor:** St. Petersburg State Pavlov Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2016-12
- **Final completion:** 2018-01
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2021-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02059512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02059512, "Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02059512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*